Results 51 to 60 of about 17,394 (260)
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen +7 more
wiley +1 more source
‘Hemp and Marijuana are both pots?’ Young consumer awareness and perception of hemp food in India
Purpose: The present study assesses consumer awareness and readiness to pay for Hemp-based food products. Hemp-based food products can help maintain insulin levels and anxiety, improve cardiac function, and thus, the potentiality to increase market ...
Rajat Goel +3 more
doaj +1 more source
Exploring new avenues: Psychedelic‐assisted therapy for young people
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou +3 more
wiley +1 more source
Bridging Disciplines: Applications of Forensic Science and Industrial Hemp
Forensic laboratories are required to have analytical tools to confidently differentiate illegal substances such as marijuana from legal products (i.e., industrial hemp). The Achilles heel of industrial hemp is its association with marijuana.
Sheree J. Finley +2 more
doaj +1 more source
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller +9 more
wiley +1 more source
Aims This work aimed to evaluate the efficacy and safety of cannabinoids for the treatment of MS‐related spasticity. Methods Systematic searches were conducted in PubMed, EMBASE, and LILACS on 2 December 2025. Randomized controlled trials evaluating natural or synthetic cannabinoids for MS‐related spasticity were included.
Letícia Hamm‐Buiar +3 more
wiley +1 more source
An ETH‐LAD trip with unfavourable consequences: A case report
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler +6 more
wiley +1 more source
The chemotaxonomic classification of Cannabis sativa L. has historically relied on the Δ9-tetrahydrocannabinol (THC) to cannabidiol (CBD) ratio, yielding canonical chemotypes I, II, and III. However, this binary framework overlooks the chemical diversity
Amonrat Mayong +3 more
doaj +1 more source
Breaking point: Identifying the factors that predict suspension from school
Abstract School suspensions are associated with adverse educational and psychosocial outcomes, yet little is known about how structural disadvantage, relational factors, health behaviours, well‐being indicators and school‐level factors jointly predict suspension risk in England.
Stephanie Cahill +5 more
wiley +1 more source
The present work studied the sources, concentrations, distributions, and possible ecotoxicological risks of trace metals (TMs) in surface sediments of the Kızılırmak and Yeşilırmak Rivers, the largest rivers in the Black Sea Region of Türkiye, and the ...
Arife Şimşek
doaj +1 more source

